Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
N/A
-37,613 Closed
0 $0
Q1 2022

May 16, 2022

BUY
N/A
7,788 Added 26.11%
37,613 $9,000
Q4 2021

Feb 14, 2022

SELL
N/A
-17,150 Reduced 36.51%
29,825 $17,000
Q3 2021

Nov 15, 2021

SELL
N/A
-655 Reduced 1.38%
46,975 $42,000
Q2 2021

Aug 16, 2021

BUY
N/A
47,630 New
47,630 $61,000
Q3 2020

Nov 16, 2020

SELL
N/A
-16,268 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
N/A
-5,134 Reduced 23.99%
16,268 $26,000
Q1 2020

May 15, 2020

BUY
N/A
7,455 Added 53.45%
21,402 $21,000
Q4 2019

Feb 14, 2020

BUY
N/A
2,977 Added 27.14%
13,947 $38,000
Q4 2018

Feb 14, 2019

BUY
N/A
194 Added 1.8%
10,970 $59,000
Q3 2018

Nov 13, 2018

SELL
N/A
-489 Reduced 4.34%
10,776 $0
Q1 2018

May 11, 2018

BUY
N/A
11,265 New
11,265 $124,000

About ALLENA PHARMACEUTICALS COM


  • Ticker ALNAQ
More about ALNAQ
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.